Modelling of human herpesvirus infections in humanized mice

Journal of General Virology

Volumn 95, Issue , 2014, Pages 2106-2117

  Berges, Bradford K ^a   Tanner, Anne ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; DRUG SCREENING; EPITHELIUM CELL; EPSTEIN BARR VIRUS INFECTION; HEMATOPOIETIC STEM CELL; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HERPES ZOSTER; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 7; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MOUSE MODEL; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; REVIEW; T LYMPHOCYTE; VIRAL GENETICS; VIRAL TROPISM; VIRUS PARTICLE; ANIMAL; DISEASE MODEL; MOUSE; PATHOLOGY; SCID MOUSE; VIROLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; HERPESVIRIDAE INFECTIONS; HUMANS; MICE; MICE, SCID;

EID: 84907210917     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.067793-0     Document Type: Review

References (86)

1. Abele-Ohl, S., Leis, M., Wollin, M., Mahmoudian, S., Hoffmann, J., Müller, R., Heim, C., Spriewald, B. M., Weyand, M. & other authors (2012). Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model. Am J Transplant 12, 1720-1729.
2. Adams, M. J. & Carstens, E. B. (2012). Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012). Arch Virol 157, 1411-1422.
3. Appleton, A. L., Sviland, L., Peiris, J. S., Taylor, C. E., Wilkes, J., Green, M. A., Pearson, A. D., Kelly, P. J., Malcolm, A. J. & other authors (1995). Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle upon Tyne Bone Marrow Transport Group. Bone Marrow Transplant 16, 777-782.
4. -/- mice. Nat Biotechnol 25, 903-910.
5. Bidanset, D. J., Rybak, R. J., Hartline, C. B. & Kern, E. R. (2001). Replication of human cytomegalovirus in severe combined immunodeficient mice implanted with human retinal tissue. J Infect Dis 184, 192-195.
6. + cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 91, 1671-1679.
7. Bravo, F. J., Cardin, R. D. & Bernstein, D. I. (2007). A model of human cytomegalovirus infection in severe combined immunodeficient mice. Antiviral Res 76, 104-110.
8. Carbone, A., Cesarman, E., Spina, M., Gloghini, A. & Schulz, T. F. (2009). HIV-associated lymphomas and gamma-herpesviruses. Blood 113, 1213-1224.
9. Chen, Q., Khoury, M. & Chen, J. (2009). Expression of human cytokines dramatically improves reconstitution of specific humanblood lineage cells in humanized mice. Proc Natl Acad Sci U S A 106, 21783-21788.
10. -/- mice as a model for Epstein-Barr virus infection. Am J Pathol 173, 1369-1378.
11. D'Agostino, G., Aricò, E., Santodonato, L., Venditti, M., Sestili, P., Masuelli, L., Coletti, A., Modesti, A., Picchio, G. & other authors (1999). Type I consensus IFN (IFN-con1) gene transfer into KSHV/ HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice. J Interferon Cytokine Res 19, 1305-1316.
12. da Silva, S. R. & de Oliveira, D. E. (2011). HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies. Cancer Lett 305, 175-185.
13. Dagna, L., Pritchett, J. C. & Lusso, P. (2013). Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. Future Virol 8, 273-287.
14. Dash, P. K., Gorantla, S., Gendelman, H. E., Knibbe, J., Casale, G. P., Makarov, E., Epstein, A. A., Gelbard, H. A., Boska, M. D. & Poluektova, L. Y. (2011). Loss of neuronal integrity during progressive HIV-1 infection of humanized mice. J Neurosci 31, 3148-3157.
15. Dittmer, D., Stoddart, C., Renne, R., Linquist-Stepps, V., Moreno, M. E., Bare, C., McCune, J. M. & Ganem, D. (1999). Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/ HHV-8) to SCID-hu Thy/Liv mice. J Exp Med 190, 1857-1868.
16. Emery, V. C., Atkins, M. C., Bowen, E. F., Clark, D. A., Johnson, M. A., Kidd, I. M., McLaughlin, J. E., Phillips, A. N., Strappe, P. M. & Griffiths, P. D. (1999). Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6. J Med Virol 57, 278-282.
17. Epstein, L. G., Cvetkovich, T. A., Lazar, E. S., DiLoreto, D., Saito, Y., James, H., del Cerro, C., Kaneshima, H., McCune, J. M. & other authors (1994). Human neural xenografts: progress in developing an in-vivo model to study human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) infection. Adv Neuroimmunol 4, 257-260.
18. Feederle, R., Haar, J., Bernhardt, K., Linnstaedt, S. D., Bannert, H., Lips, H., Cullen, B. R. & Delecluse, H. J. (2011). The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes. J Virol 85, 9801-9810.
19. Foreman, K. E., Friborg, J., Chandran, B., Katano, H., Sata, T., Mercader, M., Nabel, G. J. & Nickoloff, B. J. (2001). Injection of human herpesvirus-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions. J Dermatol Sci 26, 182-193.
20. Fuzzati-Armentero, M. T. & Duchosal, M. A. (1998). hu-PBL-SCID mice: an in vivo model of Epstein-Barr virus-dependent lymphoproliferative disease. Histol Histopathol 13, 155-168.
21. Gobbi, A., Stoddart, C. A., Malnati, M. S., Locatelli, G., Santoro, F., Abbey, N. W., Bare, C., Linquist-Stepps, V., Moreno, M. B. & other authors (1999). Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice. J Exp Med 189, 1953-1960.
22. Gorantla, S., Makarov, E., Finke-Dwyer, J., Castanedo, A., Holguin, A., Gebhart, C. L., Gendelman, H. E. & Poluektova, L. (2010). Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol 177, 2938-2949.
23. Hakki, M., Goldman, D. C., Streblow, D. N., Hamlin, K. L., Krekylwich, C. N., Fleming, W. H. & Nelson, J. A. (2014). HCMV infection of humanized mice after transplantation of G-CSF-mobilized peripheral blood stem cells from HCMV-seropositive donors. Biol Blood Marrow Transplant 20, 132-135.
24. Heuts, F., Rottenberg, M. E., Salamon, D., Rasul, E., Adori, M., Klein, G., Klein, E. & Nagy, N. (2014). T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice. J Virol 88, 3235-3245.
25. Hu, Z. & Yang, Y. G. (2012). Full reconstitution of human platelets in humanized mice after macrophage depletion. Blood 120, 1713-1716.
26. Hu, Z., Van Rooijen, N. & Yang, Y. G. (2011). Macrophages prevent human red blood cell reconstitution in immunodeficient mice. Blood 118, 5938-5946.
27. Huntington, N. D., Legrand, N., Alves, N. L., Jaron, B., Weijer, K., Plet, A., Corcuff, E., Mortier, E., Jacques, Y. & other authors (2009). IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206, 25-34.
28. + T cells in the proliferation of EBV-infected T and NK cells. PLoS Pathog 7, e1002326.
29. + cells with Epstein-Barr virus. J Virol 78, 13891-13900.
30. Kawahara, T., Lisboa, L. F., Cader, S., Douglas, D. N., Nourbakhsh, M., Pu, C. H., Lewis, J. T., Churchill, T. A., Humar, A. & Kneteman, N. M. (2013). Human cytomegalovirus infection in humanized liver chimeric mice. Hepatol Res 43, 679-684.
31. Kern, E. R. (2006). Pivotal role of animal models in the development of new therapies for cytomegalovirus infections. Antiviral Res 71, 164-171.
32. Ku, C. C., Zerboni, L., Ito, H., Graham, B. S., Wallace, M. & Arvin, A. M. (2004). Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. J Exp Med 200, 917-925.
33. Kuwana, Y., Takei, M., Yajima, M., Imadome, K., Inomata, H., Shiozaki, M., Ikumi, N., Nozaki, T., Shiraiwa, H. & other authors (2011). Epstein-Barr virus induces erosive arthritis in humanized mice. PLoS ONE 6, e26630.
34. Kwant-Mitchell, A., Ashkar, A. A. & Rosenthal, K. L. (2009). Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J Virol 83, 10664-10676.
35. Lan, K., Murakami, M., Bajaj, B., Kaul, R., He, Z., Gan, R., Feldman, M. & Robertson, E. S. (2009). Inhibition of KSHV-infected primary effusion lymphomas in NOD/SCID mice by gamma-secretase inhibitor. Cancer Biol Ther 8, 2136-2143.
36. Lebbé, C. & Francès, C. (2009). Human herpesvirus 8. Cancer Treat Res 146, 169-188.
37. Longnecker, R. M., Kieff, E. & Cohen, J. I. (2013). Epstein-Barr virus. In Fields Virology, 6th edn, pp. 1898-1959. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
38. Lusso, P. & Gallo, R. C. (1995). Human herpesvirus 6 in AIDS. Immunol Today 16, 67-71.
39. Ma, S. D., Hegde, S., Young, K. H., Sullivan, R., Rajesh, D., Zhou, Y., Jankowska-Gan, E., Burlingham, W. J., Sun, X. & other authors (2011). A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol 85, 165-177.
40. Ma, S. D., Yu, X., Mertz, J. E., Gumperz, J. E., Reinheim, E., Zhou, Y., Tang, W., Burlingham, W. J., Gulley, M. L. & Kenney, S. C. (2012). An Epstein-Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol 86, 7976-7987.
41. Macchiarini, F., Manz, M. G., Palucka, A. K. & Shultz, L. D. (2005). Humanized mice: are we there yet? J Exp Med 202, 1307-1311.
42. McCune, J. M., Namikawa, R., Kaneshima, H., Shultz, L. D., Lieberman, M. & Weissman, I. L. (1988). The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632-1639.
43. McGeoch, D. J., Rixon, F. J. & Davison, A. J. (2006). Topics in herpesvirus genomics and evolution. Virus Res 117, 90-104.
44. McGregor, A. (2010). Current and new cytomegalovirus antivirals and novel animal model strategies. Inflamm Allergy Drug Targets 9, 286-299.
45. Melkus, M. W., Estes, J. D., Padgett-Thomas, A., Gatlin, J., Denton, P. W., Othieno, F. A., Wege, A. K., Haase, A. T. & Garcia, J. V. (2006). Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12, 1316-1322.
46. Mocarski, E. S., Bonyhadi, M., Salimi, S., McCune, J. M. & Kaneshima, H. (1993). Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc Natl Acad Sci U S A 90, 104-108.
47. Mocarski, E. S., Shenk, T. & Pass, R. F. (2007). Cytomegaloviruses. In Fields Virology, 5th edn, pp. 2701-2772. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
48. Moffat, J. F., Zerboni, L., Kinchington, P. R., Grose, C., Kaneshima, H. & Arvin, A. M. (1998a). Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72, 965-974.
49. Moffat, J. F., Zerboni, L., Sommer, M. H., Heineman, T. C., Cohen, J. I., Kaneshima, H. & Arvin, A. M. (1998b). The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. Proc Natl Acad Sci U S A 95, 11969-11974.
50. Mosier, D. E. (1996). Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice. Adv Immunol 63, 79-125.
51. Mosier, D. E., Gulizia, R. J., Baird, S. M. & Wilson, D. B. (1988). Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335, 256-259.
52. Mosier, D. E., Gulizia, R. J., Baird, S. M., Spector, S., Spector, D., Kipps, T. J., Fox, R. I., Carson, D. A., Cooper, N. & other authors (1989). Studies of HIV infection and the development of Epstein- Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr Top Microbiol Immunol 152, 195-199.
53. Nash, A. A., Dutia, B. M., Stewart, J. P. & Davison, A. J. (2001). Natural history of murine c-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci 356, 569-579.
54. Orzechowska, B. U., Powers, M. F., Sprague, J., Li, H., Yen, B., Searles, R. P., Axthelm, M. K. & Wong, S. W. (2008). Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies. Blood 112, 4227-4234.
55. Parsons, C. H., Adang, L. A., Overdevest, J., O'Connor, C. M., Taylor, J. R. J., Jr, Camerini, D. & Kedes, D. H. (2006). KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/ SCID mice. J Clin Invest 116, 1963-1973.
56. Pek, E. A., Chan, T., Reid, S. & Ashkar, A. A. (2011). Characterization and IL-15 dependence of NK cells in humanized mice. Immunobiology 216, 218-224.
57. Picchio, G. R., Sabbe, R. E., Gulizia, R. J., McGrath, M., Herndier, B. G. & Mosier, D. E. (1997). The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology 238, 22-29.
58. Prichard, M. N., Quenelle, D. C., Bidanset, D. J., Komazin, G., Chou, S., Drach, J. C. & Kern, E. R. (2006). Human cytomegalovirus UL27 is not required for viral replication in human tissue implanted in SCID mice. Virol J 3, 18.
59. Quenelle, D. C., Collins, D. J., Pettway, L. R., Hartline, C. B., Beadle, J. R., Wan, W. B., Hostetler, K. Y. & Kern, E. R. (2008). Effect of oral treatment with (S)-HPMPA, HDP-(S)-HPMPA or ODE-(S)-HPMPA on replication of murine cytomegalovirus (MCMV) or human cytomegalovirus (HCMV) in animal models. Antiviral Res 79, 133- 135.
60. Reynaud, J. M., Jégou, J. F., Welsch, J. C. & Horvat, B. (2014). Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9. J Virol 88, 5421-5436.
61. Rickinson, A. B. & Kieff, E. (2007). Epstein-Barr virus. In Fields Virology, 5th edn, pp. 2655-2700. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
62. Sato, K., Misawa, N., Nie, C., Satou, Y., Iwakiri, D., Matsuoka, M., Takahashi, R., Kuzushima, K., Ito, M. & other authors (2011). A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 117, 5663-5673.
63. Shope, T., Dechairo, D. & Miller, G. (1973). Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Natl Acad Sci U S A 70, 2487-2491.
64. Shultz, L. D., Ishikawa, F. & Greiner, D. L. (2007). Humanized mice in translational biomedical research. Nat Rev Immunol 7, 118-130.
65. Shultz, L. D., Saito, Y., Najima, Y., Tanaka, S., Ochi, T., Tomizawa, M., Doi, T., Sone, A., Suzuki, N. & other authors (2010). Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rcnull humanized mice. Proc Natl Acad Sci U S A 107, 13022-13027.
66. Shultz, L. D., Brehm, M. A., Garcia-Martinez, J. V. & Greiner, D. L. (2012). Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12, 786-798.
67. Smith, M. S., Goldman, D. C., Bailey, A. S., Pfaffle, D. L., Kreklywich, C. N., Spencer, D. B., Othieno, F. A., Streblow, D. N., Garcia, J. V. & other authors (2010). Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 8, 284-291.
68. Staudt, M. R., Kanan, Y., Jeong, J. H., Papin, J. F., Hines-Boykin, R. & Dittmer, D. P. (2004). The tumor microenvironment controls primary effusion lymphoma growth in vivo. Cancer Res 64, 4790-4799.
69. Stevenson, P. G. & Efstathiou, S. (2005). Immune mechanisms in murine gammaherpesvirus-68 infection. Viral Immunol 18, 445-456.
70. Strowig, T., Gurer, C., Ploss, A., Liu, Y. F., Arrey, F., Sashihara, J., Koo, G., Rice, C. M., Young, J. W. & other authors (2009). Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med 206, 1423-1434.
71. Takahashi, M., Asano, Y., Kamiya, H., Baba, K., Ozaki, T., Otsuka, T. & Yamanishi, K. (2008). Development of varicella vaccine. J Infect Dis 197 (Suppl 2), S41-S44.
72. -/- mice. J Virol 87, 12020-12028.
73. Tanner, A., Taylor, S. E., Decottignies, W. & Berges, B. K. (2014). Humanized mice as a model to study human hematopoietic stem cell transplantation. Stem Cells Dev 23, 76-82.
74. Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J. C., Lanzavecchia, A. & Manz, M. G. (2004). Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304, 104-107.
75. Umashankar, M., Petrucelli, A., Cicchini, L., Caposio, P., Kreklywich, C. N., Rak, M., Bughio, F., Goldman, D. C., Hamlin, K. L. & other authors (2011). A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog 7, e1002444.
76. Virtanen, J. O., Färkkilä, M., Multanen, J., Uotila, L., Jääskeläinen, A. J., Vaheri, A. & Koskiniemi, M. (2007). Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications. J Neurovirol 13, 347-352.
77. Wahl, A., Linnstaedt, S. D., Esoda, C., Krisko, J. F., Martinez-Torres, F., Delecluse, H. J., Cullen, B. R. & Garcia, J. V. (2013). A cluster of virus-encoded microRNAs accelerates acute systemic Epstein-Barr virus infection but does not significantly enhance virus-induced oncogenesis in vivo. J Virol 87, 5437-5446.
78. Wang, W., Taylor, S. L., Leisenfelder, S. A., Morton, R., Moffat, J. F., Smirnov, S. & Zhu, H. (2005). Human cytomegalovirus genes in the 15-kilobase region are required for viral replication in implanted human tissues in SCID mice. J Virol 79, 2115-2123.
79. Wang, L. X., Kang,G., Kumar, P., Lu,W., Li, Y., Zhou, Y., Li, Q. &Wood, C. (2014). Humanized-BLT mouse model of Kaposi's sarcoma-associated herpesvirus infection. Proc Natl Acad Sci U S A 111, 3146-3151.
80. Washburn, M. L., Bility, M. T., Zhang, L., Kovalev, G. I., Buntzman, A., Frelinger, J. A., Barry, W., Ploss, A., Rice, C. M. & Su, L. (2011). A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 140, 1334-1344.
81. Wedderburn, N., Edwards, J. M., Desgranges, C., Fontaine, C., Cohen, B. & de Thé, G. (1984). Infectious mononucleosis-like response in common marmosets infected with Epstein-Barr virus. J Infect Dis 150, 878-882.
82. White, R. E., Rämer, P. C., Naresh, K. N., Meixlsperger, S., Pinaud, L., Rooney, C., Savoldo, B., Coutinho, R., Bödör, C. & other authors (2012). EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors. J Clin Invest 122, 1487-1502.
83. Wu, W., Rochford, R., Toomey, L., Harrington, W. J., Jr & Feuer, G. (2005). Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferonalpha. Leuk Res 29, 545-555.
84. +) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood 108, 141- 151.
85. Yajima, M., Imadome, K., Nakagawa, A., Watanabe, S., Terashima, K., Nakamura, H., Ito, M., Shimizu, N., Honda, M. & other authors (2008). A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis 198, 673-682.
86. Yajima, M., Imadome, K. I., Nakagawa, A., Watanabe, S., Terashima, K., Nakamura, H., Ito, M., Shimizu, N., Yamamoto, N. & Fujiwara, S. (2009). T cell-mediated control of Epstein-Barr virus infection in humanized mice. J Infect Dis 200, 1611-1615.